Christopher Ma, a former director of business affairs with Auburn, WA-based Syntrix Biochip, was sentenced today in U.S. District Court in Seattle to three years of supervised release, 240 hours of community service, and a $5,000 fine for making false statements. Ma, 35, was accused of submitting false audits to the National Institutes of Health, which provided $7.5 million in grants to the company over seven years for cancer research, according to a statement from the U.S. Attorney’s Office in the Western District of Washington.
Author: Luke Timmerman
Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.
View all posts by Luke Timmerman
